retatrutide reaults 28.7% Weight Loss in New Study – Dr Brad Stanfield Retatrutide Safety, Side Effects &

Head-to-head, Mounjaro consistently produces greater weight loss than Wegovy across all dose levels in clinical trial data

While the FDA prescribing information does not list hepatotoxicity as a recognized adverse effect, understanding the medication's safety profileincluding rare case reports and labeled risks like gallbladder diseasehelps patients and providers make informed treatment decisions

In the pivotal phase II clinical trial of retatrutide in obesity, published in the New England Journal of Medicine in 2023 (Jastreboff et al

Heart Rate: The One Concern Not everything looks perfect

Understand how follow-up consultations are handled, how often, and what happens if you need a dose adjustment or experience side effects

Plateau-Breaking When Cagrilintide Earns Its Layer The plateau-breaking effect is the most-asked question for users adding cagrilintide to a retatrutide protocol that has slowed